INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 54 filers reported holding INOTEK PHARMACEUTICALS CORP in Q2 2017. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $0 | – | 1 | -99.4% | 0.00% | – |
Q1 2017 | $0 | – | 181 | +1408.3% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 12 | -99.8% | 0.00% | – |
Q2 2016 | $37,000 | +48.0% | 4,909 | +47.3% | 0.00% | – |
Q1 2016 | $25,000 | -40.5% | 3,332 | -9.8% | 0.00% | – |
Q4 2015 | $42,000 | +1300.0% | 3,694 | +515.7% | 0.00% | – |
Q2 2015 | $3,000 | -85.7% | 600 | -84.2% | 0.00% | – |
Q1 2015 | $21,000 | – | 3,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
FT Options LLC | 26,421 | $299,000 | 0.22% |
EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |